TECARTUS

gilead sciences canada inc🇨🇦 Health Canada

Approval Id: 80f5ca4b30bde7e3
Drug Approval Canada Name: TECARTUS
Product Name: TECARTUS
Status: Marketed
Status Date: 2021-12-16
Original Market Date: 2021-12-16
Din: 02516667
Drug Class: Human
Dosage Form: Suspension
Route Of Administration: Intravenous
Schedule: Prescription , Schedule D
Ahfs: 26:12.00
Atc Original: L01XL06 BREXUCABTAGENE AUTOLEUCEL
Atc Name: l 01 xl 06
Aig Number: 0162968001
Company Name: gilead sciences canada inc
Company Address: 400, 6925 Century Avenue, Mississauga, Ontario, Canada, L5N 7K2

BREXUCABTAGENE AUTOLEUCEL

200000000 CELLS / BAG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

80f5ca4b30bde7e3

Type

Standard